Term ends Jul 23, 2041 · High confidence
20-year base term ends Jul 23, 2041
Held by Prothena Biosciences Limited and Othair Prothena Limited
Filed Jul 23, 2021 as application 17/383,765 · Granted Oct 7, 2025
Base term plus 286 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2021
2041
Clock starts
Jul 23, 2021
Jul 23, 2021
Term ends
Jul 23, 2041
Jul 23, 2041
Granted
Oct 7, 2025
Oct 7, 2025
base term
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
286
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,434,283.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
25
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 286 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 23, 2021, when this application, 17/383,765, was filed | Jul 23, 2041 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +286 days, USPTO patent term adjustment record | May 5, 2042 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,434,283) | capped to Jul 23, 2041 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 23, 2041 | High confidence |
This family
| Application 19/602,439 | Pending not computed | not computed |
| Application 63/055,813 | Provisional application no patent term | no patent term |
| Application 63/086,589 | Provisional application no patent term | no patent term |
| Application 63/187,379 | Provisional application no patent term | no patent term |
| Application 63/219,611 | Provisional application no patent term | no patent term |
| US 12,435,129 | this patent Jul 2041 | Jul 2041 |
| Application PCT/US2021/042900 | PCT application no patent term | no patent term |
| Application 17/510,160 | Abandoned not computed | not computed |
8 of 25 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 19, 2022 Reel 59634, frame 961 | Skov, Michael; Nijjar, Tarlochan S.; Bard, Frédérique; Barbour, Robin; Zago, Wagner | Prothena Biosciences Inc. | Assignment of Assignor's Interest |
| Apr 19, 2022 Reel 59632, frame 348 | Prothena Biosciences Inc. | Othair Prothena Limited | Assignment of Assignor's Interest |
| Apr 19, 2022 Reel 59634, frame 975 | Prothena Biosciences Inc. | Prothena Biosciences Limited | Assignment of Assignor's Interest |
| Apr 19, 2022 Reel 59634, frame 987 | Prothena Biosciences Limited | Neotope Neuroscience Limited | Assignment of Assignor's Interest |
| Apr 19, 2022 Reel 59635, frame 10 | Neotope Neuroscience Limited | Othair Prothena Limited | Assignment of Assignor's Interest |
| Apr 28, 2025 Reel 70958, frame 386 | Govindarajan, Sridhar; Purcell, Tom; Welch, Mark | Dna Twopointo, Inc. D/B/A Atum | Assignment of Assignor's Interest |
| Apr 28, 2025 Reel 70958, frame 382 | Dna Twopointo, Inc. D/B/A Atum | Prothena Biosciences Limited | Assignment of Assignor's Interest |
| Apr 28, 2025 Reel 70958, frame 423 | Dna Twopointo, Inc. D/B/A Atum | Othair Prothena Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2041
Term ends Jul 23, 2041. Maintenance fees still fall due before then
Note
The 286 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,434,283.
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.